Literature DB >> 16708705

Ocular changes with oxaliplatin.

Denise O'Dea1, Catherine M Handy, Ann Wexler.   

Abstract

Ocular toxicity, although uncommon, can occur with many chemotherapeutic agents. Platinum compounds have been documented to produce a variety of ocular side effects, and reports have been made of ocular toxicity with oxaliplatin. This article reports on four patients who experienced ocular symptoms while receiving oxaliplatin. The symptoms included tunnel vision and visual loss with postural changes. One patient had objective findings that included papilledema. All of the changes were reversible. Oxaliplatin will continue to be used widely, so clinicians treating patients with it must be alert for unusual toxicities such as those described in this article.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708705     DOI: 10.1188/06.CJON.227-229

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  5 in total

1.  Oxaliplatin-Related Ocular Toxicity.

Authors:  Marina Mesquida; Bernardo Sanchez-Dalmau; Santiago Ortiz-Perez; Laura Pelegrín; Juan José Molina-Fernandez; Marc Figueras-Roca; Ricardo Casaroli-Marano; Alfredo Adán
Journal:  Case Rep Oncol       Date:  2010-11-22

2.  Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.

Authors:  Eunhae Shin; Dong Hui Lim; Jisang Han; Do-Hyun Nam; Keunchil Park; Myung-Ju Ahn; Won Ki Kang; Jeeyun Lee; Jin Seok Ahn; Se-Hoon Lee; Jong-Mu Sun; Hyun Ae Jung; Tae-Young Chung
Journal:  BMC Ophthalmol       Date:  2020-01-09       Impact factor: 2.209

3.  Transient Vision Loss - A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases.

Authors:  Loic Ah-Thiane; Jean-Luc Raoul; Sandrine Hiret; Hélène Senellart; Frédéric Dumont; Judith Raimbourg
Journal:  Case Rep Oncol       Date:  2021-03-18

4.  Amaurosis Fugax: A Rare Oxaliplatin-Induced Ocular Toxicity - A Report of Three Cases.

Authors:  Mutahar Ali Tunio; Karen Phillips; Peter Baker
Journal:  Case Rep Oncol       Date:  2022-02-14

5.  Oxaliplatin-Associated Amaurosis Fugax.

Authors:  Kimitoshi Kubo; Noriko Kimura; Ryosuke Watanabe; Masayuki Higashino; Momoko Tsuda; Mototsugu Kato
Journal:  Case Rep Oncol       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.